Contact
Please use this form to send email to PR contact of this press release:
Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates
TO:
Please use this form to send email to PR contact of this press release:
Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates
TO: